JM
Insider selling
Jonathan Mcneill sold $370K of Crescent Biopharma, Inc. (CBIO) stock
Jonathan Mcneill, President and COO of Crescent Biopharma, Inc. (CBIO), sold 20,549 shares of CBIO stock worth $370K, per an SEC Form 4 filed Jun 23, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 22, 2026, 1 day before it was made public.
CBIO has moved -7.5% since the trade date, from $17.57 to $16.25 (Sep 21, 2026 close).
- Traded
- Jun 22, 2026
- Disclosed
- Jun 23, 2026
- Filing delay
- 1 day
- Price since
- -7.5%
- Role
- President and COO
- Source
- SEC Form 4
More CBIO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.